› Forums › General Melanoma Community › setback for Incyte and for melanoma patients
- This topic has 4 replies, 3 voices, and was last updated 6 years ago by JC.
- Post
-
- April 6, 2018 at 2:32 pm
Viewing 3 reply threads
- Replies
-
-
- April 6, 2018 at 3:21 pm
Man! This is really unfortunate news!! I had just finished writing this post:
…when I saw your link, anon. Thanks for sharing. And a big thanks to the ratties who are showing us the way. "We begin again!" celeste
-
- April 6, 2018 at 5:21 pm
Despite the first clinical trial of Keytruda/Incyte not showing significant improvement in progression-free survival in melanoma patients ,the good news is that researchers are continuing to explore how the IDO1 inhibition and other mechanism can improve outcomes for patients in needs:
-
- April 23, 2018 at 7:23 pm
-
Viewing 3 reply threads
- You must be logged in to reply to this topic.